Cover story

Restarting a Manufacturing Campus and Revitalizing a Community

Adam Covitt

Federal Equipment Company

Nice Insight Overview

The Benefits of Expanding OSD Capacity

Nigel Walker

Nice Insight

Equipment

Reshoring a Nation’s API and Pharmaceutical Production

Matt Hicks

Federal Equipment Company

Microbiome CDMO

Extensive Experience Is Crucial to Speed to the Clinic and Market for Live Biotherapeutic Products

Aaron B. Cowley, Ph.D.

ReciBioPharm

Vaccine Distribution

Anticipating the Logistics of a COVID-19 Vaccination Effort

Andrew Boyle; Marc Boyle; Patrick Schafer

Boyle Transportation

Leadership

A CEO’s Perspective: Positioning a CDMO for Significant Growth

Nicholas Green

Avid Bioservices

Parenterals

Trends Shaping the Dynamic Market for Parenterals

Marga Viñes

Grifols

Integrated CDMO

Building an Integrated and Effective CDMO from the Ground Up

Tim Tyson

TriRx Pharmaceutical Services

Recombinant Proteins

Innovation and Flexibility Drive Success During the COVID-19 Pandemic

Paul Magreta

Grifols Recombinant Protein CDMO

Decentralized Trials

Facilitating the Full Spectrum of Decentralized Trials

Mamta Trivedi

Biorasi

Northern Ireland

COVID-19 and the Growing Need for Dual-Source Supply Chains

Kevin Holland

Decentralized Trials

Protecting Clinical Research and Patients Through Decentralized Trial Strategies

Brittany Erana; Alistair Davidson

PPD, part of Thermo Fisher Scientific

Lipid Excipients

Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies

Adela Kasselkus, Ph.D.; Shiksha Mantri, Ph.D.

MilliporeSigma

Organ-on-a-Chip

Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models

Gustavo Mahler, Ph.D.; Jessica Davis

Dynamk Capital

Bioanalysis

How Bioanalysis Supports the Development of New Cell and Gene Therapies

Timothy Sangster

Celerion

Pharma/Biotech Advising

Data-Driven Decision-Making Throughout the Pharma Life Cycle

Stephan Kutzer, Ph.D.; Danielle A. Young

AKDYS

Collaboration

Better Together: Collaborating to Simplify Complexities in Drug Development

Peter Soelkner; Frank Mathias, Ph.D.

Vetter Pharma International GmbH

CRISPR RNPs

CRISPR RNPs and the Future of Cell and Gene Therapy

Thomas Lynch, Ph.D.

Aldevron

Supply Chain

Introduction: The Evolving Pharmaceutical Supply

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Feature Story

The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac